Central Actions of Somatostatin-28 and Oligosomatostatin Agonists to Prevent Components of the Endocrine, Autonomic and Visceral Responses to Stress Through Interaction with Different Somatostatin Receptor Subtypes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|1|98-105

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.1, 2013-01, pp. : 98-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin receptor agonists and antagonists

By Crider A Michael  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1427-1441

Informa Healthcare

Access to resources Recommend Favorite

Delineating Somatostatin's Neuronal Actions

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 2, 2004-04 ,pp. : 153-160

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple actions of somatostatin in neoplastic disease

By Reubi J.-C.   Laissue J.A.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 3, 1995-03 ,pp. : 110-115

Elsevier

Access to resources Recommend Favorite

Somatostatin analogues in the treatment of endocrine tumours of the gastrointestinal tract

By Behr TH   Arnold R   Wied M  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 643-656

Informa Healthcare

Access to resources Recommend Favorite

Targeting the somatostatin receptor in pituitary and neuroendocrine tumors

By Veenstra Marije J   de Herder Wouter W   Feelders Richard A   Hofland Leo J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1329-1343

Informa Healthcare

Access to resources Recommend Favorite